Literature DB >> 9645176

Tamoxifen and breast cancer prevention: what should you tell your patients?

V Goel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9645176      PMCID： PMC1229413     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  11 in total

1.  NIH fends off critics of tamoxifen study.

Authors:  R Stone
Journal:  Science       Date:  1992-10-30       Impact factor: 47.728

2.  Tamoxifen for the prevention of breast cancer. Important questions remain unanswered, and existing trials should continue.

Authors:  P Bruzzi
Journal:  BMJ       Date:  1998-04-18

Review 3.  Epidemiology and prevention of breast cancer.

Authors:  J L Kelsey; L Bernstein
Journal:  Annu Rev Public Health       Date:  1996       Impact factor: 21.981

Review 4.  Primum non nocere? Valuing of the risk of drug toxicity in therapeutic decision making.

Authors:  L A Lenert; D R Markowitz; T F Blaschke
Journal:  Clin Pharmacol Ther       Date:  1993-03       Impact factor: 6.875

5.  Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women.

Authors:  S E Karp; P N Tonin; L R Bégin; J J Martinez; J C Zhang; M N Pollak; W D Foulkes
Journal:  Cancer       Date:  1997-08-01       Impact factor: 6.860

Review 6.  Tamoxifen: toxicities and drug resistance during the treatment and prevention of breast cancer.

Authors:  V C Jordan
Journal:  Annu Rev Pharmacol Toxicol       Date:  1995       Impact factor: 13.820

Review 7.  Tamoxifen for the primary prevention of breast cancer: a review and critique of the concept and trial.

Authors:  T L Bush; K J Helzlsouer
Journal:  Epidemiol Rev       Date:  1993       Impact factor: 6.222

Review 8.  Antiestrogens as chemopreventive agents in breast cancer: promise and issues in evaluation.

Authors:  R R Love
Journal:  Prev Med       Date:  1989-09       Impact factor: 4.018

Review 9.  Alternate antiestrogens and approaches to the prevention of breast cancer.

Authors:  V C Jordan
Journal:  J Cell Biochem Suppl       Date:  1995

10.  The decision to enter a randomized trial of tamoxifen for the prevention of breast cancer in healthy women: an analysis of the tradeoffs.

Authors:  R F Nease; J M Ross
Journal:  Am J Med       Date:  1995-08       Impact factor: 4.965
View more
  2 in total

1.  Tamoxifen for breast cancer chemoprevention: low uptake by high-risk women after evaluation of a breast lump.

Authors:  Rebecca Taylor; Kenneth Taguchi
Journal:  Ann Fam Med       Date:  2005 May-Jun       Impact factor: 5.166

Review 2.  Hereditary breast cancer. Identifying and managing BRCA1 and BRCA2 carriers.

Authors:  R E Heisey; J C Carroll; E Warner; D R McCready; V Goel
Journal:  Can Fam Physician       Date:  1999-01       Impact factor: 3.275
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.